Last year, a team of researchers at the Case Western Reserve University School of Medicine studied 1.6 million patients with type 2 diabetes and found that those on GLP-1 drugs had significant risk reduction of ten cancers: esophageal, colorectal, endometrial, gallbladder, kidney, liver, ovarian, and pancreatic cancer, as well as meningioma and multiple myeloma
The condition predominantly affects males with a ratio of approximately 5 males for every female
Please note the Altrient products are not intended to prevent, cure or treat any specific health condition or disease
Considering that all of the patients had underlying diseases such as inflammatory bowel disease, colon cancer, and chronic cholecystitis, and that they had all undergone the trauma of surgery and bowel manipulation, the probability that BT exists in the absence of disease or trauma is low
Save this post if you're starting a GLP-1 journey, and follow Call-On-Doc for more weight loss tips and expert guidance